These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15688074)

  • 1. Multicomponent therapeutics for networked systems.
    Keith CT; Borisy AA; Stockwell BR
    Nat Rev Drug Discov; 2005 Jan; 4(1):71-8. PubMed ID: 15688074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the search for drugs to treat central nervous system disorders.
    Enna SJ; Williams M
    J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
    Rivers EC; Mancera RL
    Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-target therapeutics: when the whole is greater than the sum of the parts.
    Zimmermann GR; Lehár J; Keith CT
    Drug Discov Today; 2007 Jan; 12(1-2):34-42. PubMed ID: 17198971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hands-on molecular imaging: real-time visualization tools bridge gaps in translational medicine.
    Vanderheyden JL
    IDrugs; 2008 Aug; 11(8):579-83. PubMed ID: 18683093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapy.
    Kieburtz K; Olanow CW
    Mt Sinai J Med; 2007 Apr; 74(1):7-14. PubMed ID: 17516559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fangjiomics: in search of effective and safe combination therapies.
    Wang Z; Liu J; Cheng Y; Wang Y
    J Clin Pharmacol; 2011 Aug; 51(8):1132-51. PubMed ID: 21209238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine.
    Sulica R; Poon M
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):347-60. PubMed ID: 15853607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical approaches to the discovery and development of cancer therapies.
    Neidle S; Thurston DE
    Nat Rev Cancer; 2005 Apr; 5(4):285-96. PubMed ID: 15803155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting disease, not disease targets: Innovative approaches in tackling neurodegenerative disorders.
    Griffioen G
    IDrugs; 2007 Apr; 10(4):259-63. PubMed ID: 17390249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for fMRI in optimizing CNS drug development.
    Borsook D; Becerra L; Hargreaves R
    Nat Rev Drug Discov; 2006 May; 5(5):411-24. PubMed ID: 16604100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus issue: drug discovery.
    Gough NR
    Sci STKE; 2005 Aug; 2005(295):eg7. PubMed ID: 16077084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development.
    Hermiston TW; Kirn DH
    Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone, rosiglitazone, and rosiglitazone + metformin: new drugs. Glitazone + oral antidiabetic combination: inadequately evaluated.
    Prescrire Int; 2005 Aug; 14(78):133-9. PubMed ID: 16106595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-sparing regimens for HIV combination therapy: benefits predicted for "drug coasting".
    Krakovska O; Wahl LM
    Bull Math Biol; 2007 Nov; 69(8):2627-47. PubMed ID: 17578648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid molecules with a dual mode of action: dream or reality?
    Meunier B
    Acc Chem Res; 2008 Jan; 41(1):69-77. PubMed ID: 17665872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can FLT3 inhibitors overcome resistance in AML?
    Tam WF; Gary Gilliland D
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):13-20. PubMed ID: 18342808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems biology and combination therapy in the quest for clinical efficacy.
    Fitzgerald JB; Schoeberl B; Nielsen UB; Sorger PK
    Nat Chem Biol; 2006 Sep; 2(9):458-66. PubMed ID: 16921358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.